// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Novel three‐dimensional imaging of the fetal kidneys in the first trimester

H. Shah - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Renal dysplasia, cystic

N/A

Pregnancy in a non‐communicating rudimentary horn: diagnostic challenges and late sonographic diagnostic criteria

G. Verma - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

Methadone hydrochloride

Ultrasound characteristics of retained products of conception: could the type of measurement help in the choice of treatment options offered?

M. Oniah - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultra‐high magnification (IMSI) vs standard sperm selection (ICSI) for assisted reproduction

D.M. Teixeira - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Normal/arcuate vs septate uterus: agreement between currently recommended cut‐off values for measurements and experts' opinion

A. Ludwin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Normal/arcuate vs septate uterus: diagnostic test accuracy and best cut‐off values for currently used measurements

A. Ludwin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Normal/arcuate vs septate uterus: interobserver reliability/agreement of currently used measurements

A. Ludwin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Venous thromboembolism secondary to massive uterine leiomyoma

J.P. Jayasinghe - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Tinzaparin

Survey on selecting patients with postmenopausal bleeding (PMB) for hysteroscopy: current practice and future clinical effectiveness

E. Zielinski - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Descriptive study on PMB patients, who referred to RAC (rapid access clinic) in Queen Elizabeth Hospital, Gateshead

J.P. Jayasinghe - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical utility of IOTA models, RMI and ROMA to refer patients with adnexal masses to specialised oncology care

L. Wynants - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultrasound‐guided laparoscopic ovarian wedge resection in recurrent serous borderline ovarian tumours

S. Saso - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sonographic prediction of mode of delivery: a multicentre, prospective cohort study

B.H. Kahrs - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The tramline sign for abnormally invasive placenta using Crystal Vue with flow

A. Dall'Asta - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Placenta previa

N/A

Birth weight differences at term are explained by the gender, gestational age and placental dysfunction, but not by ethnicity

J. Morales-Rosell - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Placental insufficiency

N/A

Novel placental evaluation using multimodal MRI

R. Pratt - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective validation of International Ovarian Tumour Analysis (IOTA) malignancy indicators for adnexal masses: a 4‐year study from a single centre

S. Johnson - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sonographic prediction of length of vacuum deliveries: a multicentre, prospective cohort study

B.H. Kahrs - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An audit on the management of suspected cases of morbidly adherent placenta at the Heart of England Foundation Trust: a pathway to enhance patient care

A. Fatma - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Placenta accreta spectrum

N/A

Thermal and mechanical index for obstetric scans: an analysis

L. Wing Fai - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved